These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12604559)

  • 1. Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.
    Hoellman DB; Lin G; Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1148-50. PubMed ID: 12604559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
    Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
    Mathur T; Singhal S; Khan S; Bhateja P; Pandya M; Rattan A; Bhatnagar PK; Upadhyay DJ; Fatma T
    J Chemother; 2008 Aug; 20(4):420-7. PubMed ID: 18676219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
    Ednie LM; Pankuch G; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4027-32. PubMed ID: 15388472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
    Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria.
    Mathur T; Bhateja P; Pandya M; Fatma T; Rattan A
    Int J Antimicrob Agents; 2004 Oct; 24(4):369-73. PubMed ID: 15380263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
    Credito K; Lin G; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4033-6. PubMed ID: 15388473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.
    Kalia V; Miglani R; Purnapatre KP; Mathur T; Singhal S; Khan S; Voleti SR; Upadhyay DJ; Saini KS; Rattan A; Raj VS
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1427-33. PubMed ID: 19075051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.
    Mathur T; Kalia V; Barman TK; Singhal S; Khan S; Upadhyay DJ; Rattan A; Raj VS
    Int J Antimicrob Agents; 2013 Jan; 41(1):36-40. PubMed ID: 23142085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.
    Lin G; Credito K; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):770-2. PubMed ID: 15673763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacodynamics of a new oxazolidinone (linezolid).
    Andes D; van Ogtrop ML; Peng J; Craig WA
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
    Das B; Rudra S; Yadav A; Ray A; Rao AV; Srinivas AS; Soni A; Saini S; Shukla S; Pandya M; Bhateja P; Malhotra S; Mathur T; Arora SK; Rattan A; Mehta A
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4261-7. PubMed ID: 16054358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
    Jorgensen JH; McElmeel ML; Trippy CW
    Antimicrob Agents Chemother; 1997 Feb; 41(2):465-7. PubMed ID: 9021209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent North American isolates of Streptococcus pneumoniae.
    Baum SE; Crawford SA; McElmeel ML; Whitney CG; Jorgensen JH
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3094-5. PubMed ID: 12183281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom.
    Johnson AP; Warner M; Livermore DM
    J Antimicrob Chemother; 2000 Feb; 45(2):225-30. PubMed ID: 10660506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.
    Pankuch GA; Kelly LM; Lin G; Bryskier A; Couturier C; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3270-4. PubMed ID: 14506040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal activity of dalbavancin compared to other agents.
    Lin G; Smith K; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5182-4. PubMed ID: 16304200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.